Natera Launches Proposed Follow-On Offering Of $250M
Portfolio Pulse from Benzinga Newsdesk
Natera, a genetic testing company, has announced a proposed follow-on offering of $250 million. The funds raised will be used for general corporate purposes.
September 06, 2023 | 8:24 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Natera's proposed follow-on offering of $250 million could dilute existing shareholders' equity, potentially leading to a short-term decrease in stock price.
Follow-on offerings often lead to dilution of existing shareholders' equity, which can result in a decrease in stock price. However, the funds raised can also be used to fuel growth, which could have positive long-term effects.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100